The United States has lost its measles elimination status, a distinction it had held for 26 years, according to the Pan American Health Organization (PAHO). The same lineage of the virus has spread from person to person in the United States for at least a year, meeting the criteria for measles transmission to be considered reestablished.
This situation poses serious risks, especially for young children and individuals with weakened immune systems. In areas where measles is still circulating, unvaccinated kids—including babies who are too young for their first shot—face greater exposure risks.
Measles-Associated Deaths on the Rise
Recent reports of measles-associated deaths in several states, including New York, Wisconsin, and Pennsylvania, highlight the severity of the situation. As of November 13, the Centers for Disease Control and Prevention (CDC) had recorded more than 5,400 cases, more than twice the total for all of 2025.
Three states, Pennsylvania, Wisconsin, and New York, have documented a combined 11 measles-related fatalities this year, while the CDC’s preliminary nationwide total stands at six. The difference likely stems from varying standards used to determine whether measles played a role in deaths.
The federal death toll may climb as additional records are processed and investigations conclude. The CDC should clarify publicly why the figures differ and collaborate with state health officials to adopt uniform reporting criteria.
Regaining Elimination Status
To reclaim measles-free status, the U.S. must demonstrate at least 12 months without sustained outbreaks, backed by consistent surveillance data. Achieving this will require targeted efforts to boost vaccination rates in low-coverage areas.
Two doses of the measles, mumps, and rubella (MMR) vaccine are about 97% effective at preventing measles. However, vaccination coverage among U.S. kindergartners fell from 95.2% in the 2019-2020 school year to 92.4% in 2025-2026, leaving an estimated 280,000 kindergarteners without the protection of both doses.
The new Congress must allocate funds for health departments to partner with schools and clinics in underserved communities. Resources should cover outreach to families with overdue vaccinations, address safety concerns, and offer flexible scheduling, including evenings and weekends.
Related Post: CDC Revises Measles Death Count Amid Pennsylvania Controversy
By November 13, Pennsylvania’s state health center staff had administered more than 7,100 MMR doses at pop-up clinics in affected communities. Health departments should be able to do this work before an outbreak occurs, and Congress can track the effectiveness of the funding by monitoring improvements in vaccination coverage down to the county or school district level.
A pediatrician who has worked with patients and families affected by measles outbreaks notes that people want to know what the evidence shows, what is still being learned, and what side effects to expect from vaccines. They want enough information to make an empowered decision for themselves and their families.
A recent national survey revealed that over half of U.S. adults trust the CDC’s vaccine information. When asked who they’d rely on in conflicting advice, 30% chose the CDC, though most still prioritized their personal healthcare providers.
The incoming House and Senate health committees should hold public hearings to ask Department of Health and Human Services leaders to explain the evidence behind changes to vaccine recommendations made over the past two years. Congress should require HHS to publish those answers when it announces a change, so that clinicians can explain the decision to patients.
The same health departments that help schools close vaccination gaps also need to respond when a clinician calls about a suspected case. They need someone to answer after hours, a lab that can test a specimen promptly, and staff who can reach exposed families while there’s still time to help. Congress should fund this capacity year-round and direct HHS and the CDC to publish a plan for regaining elimination status, with clear responsibilities and deadlines.
Congress should also ask the CDC to report publicly each quarter on whether two-dose MMR coverage is rising in the communities with the largest gaps and if it is not increasing, to explain what the challenges are to vaccination. The agency should provide information about how quickly suspect cases are investigated and where chains of transmission remain active.
These reports would help Congress understand where more help is needed and build the record the U.S. needs to demonstrate at least 12 months without sustained measles transmission. A clinician who has spent much of her career responding to outbreaks notes that every month of delay leaves more families exposed to a deadly disease that can be prevented with vaccination.
